[{"id":"2b50d005-f052-4b55-a69c-67be5aa27c38","acronym":"","url":"https://clinicaltrials.gov/study/NCT02430480","created_at":"2021-01-18T11:37:46.360Z","updated_at":"2024-07-02T16:35:42.119Z","phase":"Phase 2","brief_title":"Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer","source_id_and_acronym":"NCT02430480","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" PTEN • AR • ERG","pipe":" | ","alterations":" ERG overexpression","tags":["PTEN • AR • ERG"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ERG overexpression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Xtandi (enzalutamide) • goserelin acetate"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 39","initiation":"Initiation: 06/03/2015","start_date":" 06/03/2015","primary_txt":" Primary completion: 12/01/2019","primary_completion_date":" 12/01/2019","study_txt":" Completion: 06/01/2025","study_completion_date":" 06/01/2025","last_update_posted":"2023-07-25"},{"id":"12905d7e-54ef-443e-bcc1-4ec13581d13b","acronym":"","url":"https://clinicaltrials.gov/study/NCT00898092","created_at":"2021-05-11T12:52:30.151Z","updated_at":"2024-07-02T16:36:26.247Z","phase":"","brief_title":"Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia","source_id_and_acronym":"NCT00898092","lead_sponsor":"Alliance for Clinical Trials in Oncology","biomarkers":" BAALC","pipe":" | ","alterations":" ERG overexpression","tags":["BAALC"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ERG overexpression"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 735","initiation":"Initiation: 05/01/2006","start_date":" 05/01/2006","primary_txt":" Primary completion: 12/01/2012","primary_completion_date":" 12/01/2012","study_txt":"","study_completion_date":"","last_update_posted":"2021-08-17"}]